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Hydrogen peroxide, a secretory product of mononuclear phagocytes (1), accounts for a considerable portion of their nonphagocytic lysis of tumor cells in at least three circumstances: when certain secretagogues are added (2) (3) (4) , when antitumor antibody is present (5, 6) , or when the tumor cells are coated with eosinophil peroxidase. 1 Granulocytes also secrete H202, which may participate in their cytotoxic effects in a variety of situations (7) (8) (9) (10) (11) (12) (13) . Finally, preformed or enzymatically generated H202, with or without a peroxidase, lyses tumor cells (2, (14) (15) (16) (17) (18) (19) .
In the present study we sought to devise a nontoxic way to deliver hydrogen peroxide to sites of malignancy in vivo and to test its antitumor efficacy. Glucose oxidase was chosen for this purpose because its substrates, glucose and oxygen, are abundant in the body fluids, because its sole products are H202 and gluconic acid (20) , and because a flux of H~O2 generated enzymatically in situ might be less toxic than injection of preformed H202. To prolong the retention of the H~O2-generating system at the site of administration, glucose oxidase was coupled covalently to polystyrene microspheres.
Below are described the distribution of parenterally injected glucose oxidase-latex particles (GOL), 2 their antitumor effect in the peritoneal cavity and subcutaneous tissues of the mouse, the role of supplemental oxygen, the synergy between GOL and another antitumor agent capable of inhibiting a major peroxide-catabolizing pathway in tumor cells, and the relative lack of toxicity of this novel treatment.
Materials and Methods
Coupling of Enzymes to Polystyrene Microspheres. Carboxylated latex particles were obtained as a 10% suspension from Dow Chemical Co., Indianapolis, Ind. The manufacturer reported their diameter as 0.907 :l: 0.0061 /~m (mean + SD). 13.2 ml of latex suspension was washed three times by centrifugation at 15,000 g for 15 min at 4°C in 30 ml 0.2 M sodium acetate buffer, pH 5.4. The pellet was resuspended in 44 ml of the buffer and mixed with 26.1 ml of glucose oxidase (fl-D-glucose:oxygen 1-oxidoreductase, E.C. 1.1.3.4, type V, from Aspergillus niger), representing ~160 mg of protein with an activity of 1,050-1,400 Sigma units/ml (Sigma Chemical Co., St. Louis, Mo.), or with the same volume of catalase from beef liver, catalog number C 100 from Sigma Chemical Co., representing about 886 mg of protein with an activity of 1.17 × 106 Sigma units/ml (one Sigma unit of glucose oxidase catalyzes the oxidation of 1 #mole of ~-D-glucose/min at 35°C in air-saturated buffer, pH 5.1; one Sigma unit ofcatalase degrades 1 ~mole of H202/min at 25°C in 0.05 M phosphate buffer, pH 7.0). Immediately before use, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide-metho-p-toluenesulfonate (Aldrich Chemical Co., Milwaukee, Wis., or Sigma Chemical Co.) was dissolved in the acetate buffer at a concentration of 254 mg/ml, and 17.6 ml was added to the latex-enzyme suspension, which was then stirred for 30 rain at 4°C. After centrifugation, the pellet was resuspended in 44 ml of 1 M glycine (Fisher Scientific Co., Fair Lawn, N. J.), and the suspension was stirred for 30 min at room temperature. The latex was then washed four times by centrifugation in 30 ml of 0.9% NaCI and resuspended in 21 ml of 0.9% NaCl. Where indicated, the beads were boiled for 20 min to inactivate the enzyme.
Tests of Enzyme-coupled Beads. H202 production by GOL was measured by the loss of fluorescence due to oxidation of scopoletin in the presence of horseradish peroxidase at 37°C, as described (1) . The buffer (Krebs-Ringer phosphate) (1) was equilibrated with air, contained 5.5 mM glucose, and had a pH of 7.35-7.40. The Km of GOL for glucose was determined by measuring the initial rate of H202 production (V) at various concentrations of glucose (S) and plotting V/S vs. V (Kin for glucose = 16.7 mM; correlation coefficient = 0.95). The Kr, of GOL for 02 was estimated in an oxygen polarograph (Yellow Springs Instrument Co., Yellow Springs, Ohio) using Krebs-Ringer phosphate buffer with 100 mM glucose at 37°C in the presence of 1,744 Sigma units/ml of catalase. Under these conditions, H202 production was assumed to be twice the observed oxygen consumption. The curve of H202 produced (y) vs. time (x) fit the function, y = a + b In (x), with a correlation coefficient of 0.99. The first derivative of this function was used to determine instantaneous rates of H202 formation (I 0 at given 02 concentrations (S). A plot of V/S vs. Vindicated a Km for 02 of 0.01 mM (correlation coefficient = 0.94). The activity of catalase-latex was measured by determining the number of beads that reduced by 50% the rate of H202 generation (1.3 nmol/min) by glucose oxidase and was compared with the volume of native catalase solution necessary to achieve the same result. The specific activity of the catalase-latex was 7.5% of that of the initial enzyme preparation. The number of latex beads per milliliter was determined in a hemocytometer with a ×40 water immersion objective with phase contrast. The protein content of the native and bound enzyme preparations was measured by the method of Lowry et al. (21) with a bovine serum albumin standard. The sterility of the final latex suspensions was assessed by streaking 0.01-ml aliquots on two to four tryptic soy broth agar plates with or without sheep's blood.
Treatment of Mice.
(BALB/c × DBA/2)Fx (CD2F1) female mice were obtained from Simonsen Laboratories, Gilroy, Calif., or from Charles River Breeding Laboratories, Wilmington, Mass. and entered into experiments at 7-14 wk of age. In several experiments DBA/2 mice (The Jackson Laboratory, Bar Harbor, Maine) or (DBA/2 × BALB/c)F1 (D2CFx) mice from Trudeau Institute, Saranac L/~ke, N. Y. were used. In a given experiment, all mice were of one strain, chosen randomly from a single shipment from one supplier, and were within 1 wk of each other in age. P388 lymphoma and P815 mastocytoma were maintained by passage of ascites (19) . For experiments, the cells were washed by centrifugation in Eagle's minimum essential medium (MEM), alpha variant, containing 100 U/ml penicillin and 100 #g/ml streptomycin (Flow Laboratories, Inc., Walkersville, Md.) and counted in a hemocytometer. The desired number of cells in 0.5-1.0 ml of MEM was injected intraperitoneally (i.p.). GOL or an equivalent volume of 0.9% NaC1 was then given through a separate i.p. injection.
For experiments involving 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) (Bristol Laboratories, Syracuse, N. Y.), the mean weight of the mice was used to calculate a dose of 30 mg/kg. Sterile BCNU was dissolved in absolute ethanol and diluted in MEM so that the desired amount was injected i.p. in 0.5 ml, with a final ethanol concentration of 2%. Controls received 0.5 ml of MEM-2% ethanol.
Some of the mice were exposed for 2-3.5 h to 100% oxygen saturated with water at 1 atm pressure by placing them in a gas-tight lucite chamber into which 02 (Matheson Gas Products, East Rutherford, N. J.) was passed after bubbling through water. Gas exited through a water seal, in which the 02 tension exceeded 500 mm Hg when the chamber was fully occupied. The chamber temperature was maintained at 24.0°-25.5°C by a water jacket connected to a circulating temperature regulator.
For experiments with subcutaneous (s.c.) tumors, P388 cells were suspended in Krebs-Ringer phosphate buffer without glucose and injected through a 26-gauge needle under the abdominal skin in a volume of 0.1 ml.
Where indicated, 30% hydrogen peroxide (analytical grade, Mallinckrodt, Inc., Paris, Ky.) was assayed by the scopoletin method, diluted in 0.9% NaCI, and injected i.p. Ethylhydroperoxide and cumenehydroperoxide were from Polysciences, Inc., Warrington, Pa.
Other Tests. 15 min after i.p. injection of BCNU into mice bearing advanced P815 ascites, the tumor cells were collected, washed three times at 4°C in Dulbecco's phosphate-buffered saline (Grand Island Biological Co., Grand Island, N. Y.), and assayed for glutathione reductase as described (19) . Serum levels of glucose, urea nitrogen, creatinine, bilirubin, glutamic-pyruvic transaminase, and creatine phosphokinase were measured in the clinical laboratories of The New York Hospital by standard methods. The erythroeyte count was determined with a hemocytometer.
Estimation of the Percent Killing of P388. In three separate experiments, survival time was determined for groups of mice (5-33 per group) injected i.p. with P388 cells ranging in number over three to seven orders of magnitude. Survival in days (x) was plotted against log10 cells injected (y), and the best fit of the data determined to the equation, y = ax + b, by linear regression. The following assumptions were made: that all dividing tumor cells gave rise to two daughters, each of which divided; that generation time was constant until death of the host; and that all hosts died when a fixed number of P388 cells was attained. Then, doubling time of the tumor cells in hours = t~ = 240og 2)/(-a). Using the mean td from the three experiments (14.28 + 1.94 h), the percent tumor cell kill in a given experiment with GOL was estimated as 100(1 -[2~n/~]-1), where n ffi days of increased survival compared with controls.
Results
Characteristics of GOL.
The properties of nine consecutive preparations of GOL are summarized in Table I . The average GOL suspension contained 5.8 X 101° beads/ml. In air-saturated buffer at pH 7.4 with 5.5 mM glucose, 1 ml of beads typically produced 172 nmol H202/min (range, 99-315). 99-100% of this activity was sedimentable in a microfuge or retained by a filter (0.22/~m pore size) and thus appeared to be bound to the beads. On the average, 1.4% of the added protein was coupled to the beads; their specific activity was 17% of that of the initial enzyme preparation.
Fate of GOL after i.p. Injection. Between 4 and 8 h after injection, most of the fluid of the GOL suspension was cleared from the peritoneal cavity, leaving from 10 to 100 tightly packed macroscopic aggregates of latex particles along the anterior peritoneal lining and the mesentery, in the peripancreatic fat, against the serosal surfaces of the stomach and spleen, between the lobes of the liver, and along the inferior surfaces of the diaphragms. By 13 h, peritoneal lavage recovered only 0.045% of the injected GOL as free particles, with an enzymatic activity ~50% of that of an equivalent number of uninjected particles. Also recovered were 4 × 10 e leukocytes, 75% neutrophilic, each containing ~20 GOL particles with activity ~ 10% of that of an equivalent number of uninjected beads. The GOL aggregates contained rare mononuclear cells at 4 h and were then gradually infiltrated with small numbers of polymorphonuclear 2.2-37.1 negative leukocytes through the second day. At that time, the vast majority of particles remained extracellular. However, by day 7, the aggregates were heavily infiltrated with mononuclear phagocytes, which engulfed almost all the particles. These inflammatory changes were limited to the aggregates of GOL themselves. There was no gross or histologic evidence of GOL particles or inflammation elsewhere in the peritoneal cavity or in the following organs: brain, eyes, salivary glands, submandibular lymph nodes, lungs, thymus, heart, diaphragms, stomach, duodenum, small bowel, colon, liver, spleen, mesenteric nodes, pancreas, kidneys, adrenals, uterus, ovaries, skeletal muscles, bones, or marrow. At 5 and 10 mo after injection of GOL, the histologic picture was essentially the same as on day 7, except for the appearance of GOL in rare Kupffer's cells by 10 mo. When 106 P388 cells were injected i.p., followed by 1 ml ofGOL i.p., the mice lived an average of 3.2 d (27%) longer than those receiving tumor cells and saline. These results were observed in eight experiments, each with a different preparation of GOL. This prolongation of survival was consistent with the destruction by GOL of an average of 97.6% of the tumor cell inoculum (Table II) .
Prolongation of Survival after i.p. Injection of GOL and 106 P388 Lymphoma
Enzymatic activity of the beads appeared to be necessary, because the injection of boiled beads did not prolong survival (Table II) . Such beads produced H202 at a rate averaging 0.3% of that seen with unboiled GOL. Furthermore, coupling of glucose oxidase to the beads was required, because administration of soluble glucose oxidase with an enzymatic activity equivalent to 3 ml of GOL afforded no increase in survival (Table II) . The dose of soluble glucose oxidase tested in this experiment corresponded to the dose lethal to 10% of the mice, as determined in preliminary experiments, and was 65% of the dose lethal to 50% of the mice. Thus, it was the highest dose of soluble glucose oxidase that could be tested for therapeutic benefit.
In contrast, the use of no more than 1 ml of GOL per mouse was dictated by its cost, not by toxicity (see below). In two experiments, 0.3 or 0.1 ml of GOL did not prolong survival after injection of 106 P388 cells (not shown).
Effect of Interval between Injection of GOL and P388. The tight packing of GOL in
aggregates -3 h after its injection presumably restricted diffusion of substrates and products. To estimate the duration of effective enzymatic activity of GOL and to evaluate the role of inflammatory cells, GOL was injected 20, 6, 3, 1, and 0 h before 106 P388 cells. GOL was effective if injected 0 or 1 h before P388, but not if injected 3-20 h before. In contrast, the modest number of inflammatory cells detected in the peritoneal washings peaked at the latter times, when an antitumor effect was no longer evident (Fig. 2) . This suggested that GOL exerted its effect over the first few hours by a mechanism independent of newly arriving inflammatory cells.
Effect of Supplemental Substrates. In vivo, the concentrations of oxygen and glucose are probably suboptimal for glucose oxidase (20, (22) (23) (24) (25) (26) . Table III shows the effect of exposing mice to 100% 02 at 1 atm for 2-3.5 h after injection of 106 P388 cells and 1 ml GOL i.p. In five experiments, survival was prolonged an average of 4.7 d (42%), consistent with destruction of 99.6% of the tumor cell inoculum. Supplemental 02 had no effect on the survival of mice given P388 without GOL (cf . Tables II and III) .
Supplemental glucose in various amounts up to 0.36 mmol per mouse (presumably enough to triple the blood glucose concentration) did not prolong survival from P388 lymphoma, when injected alone, with GOL, or with GOL plus supplemental 02 (not shown). Dependence of the Antitumor Effect on He 02. Reversal of the antitumor effect of GOL by boiling the beads indicated a need for enzymatic activity (Table II) but did not identify which of the three enzymatic effects of glucose oxidase was most important: production of H202, production of gluconic acid, or consumption of glucose. To make this distinction, mice were injected simultaneously with P388, with GOL, and with latex beads to which catalase had been covalently coupled, and then given supplemental Oz for 2 h. As shown in Table IV , catalase-latex alone had no effect on the survival of the mice. GOL prolonged their survival by 4.8 d, consistent with killing 99.6% of the P388 cells. Catalase-latex abolished the effect of GOL. Since catalase would be expected to break down H202, without affecting the consumption of glucose or production of acid by GOL, it appeared that H202 was necessary for the antitumor effect of GOL.
Effect of GOL against Lower Doses of P388 i.p. No mice were cured by GOL after
being injected with 106 P388 cells i.p. However, injection of 1 ml GOL led to longterm survival of increasing proportions of mice injected with fewer P388 cells. Two such experiments, with observation periods in excess of 441 and 303 d, are illustrated in Fig. 3 . GOL appeared to cure 23% of the mice after injection of 105 P388 ceils, 77% after 104 cells, and 92% after 103 cells. Boiled GOL cured no mice, even when only 103 P388 cells were injected (Fig. 3) . In addition, soluble glucose oxidase, at a dose Fro. 3. Survival of mice injected with the indicated numbers of P388 cells i.p. followed by 1 ml of the following: GOL (glucose oxidase-latex), BGOL (boiled GOL), NS (normal saline), or SGO (soluble glucose oxidase, 5 Sigma units). There were seven mice per group followed for 441 d in the experiment shown in A, and 6 mice per group followed for 303 d in B.
equivalent to 3 ml of GOL, cured none of the mice injected with as few at 104 P388 cells (Fig. 3) , nor even prolonged their survival ( Glucose was not present in the syringe containing GOL and tumor cells, so the antitumor effect seen with GOL and not with boiled GOL presumably commenced after injection. Nonetheless, three of the mice without local nodules died from metastases. When the number of beads was tripled, boiled GOL also began to suppress nodule formation (data not shown).
Effect of GOL against a Peroxide-resistant Tumor." Synergy with BCNU. P815 mastocy-
toma cells require ,,,4.2 times more glucose oxidase to lyse 50% of the cells than do P388 lymphoma cells (19) . 1 ml of GOL did not prolong the survival of mice injected with 106 P815 cells i.p., whether or not the mice received supplemental 02 (not shown). However, in vitro, it is possible to increase the susceptibility of P815 cells to lysis by glucose oxidase by an average of 5.5-fold by exposing the cells to BCNU (19) . This effect of BCNU appears to be due to its inhibition of tumor cell glutathione reductase (19) . Accordingly, we determined the dose of BCNU necessary to inhibit glutathione reductase in P815 ascites cells in vivo (Fig. 5) . 30 mg BCNU/kg, the highest nonlethal dose tested (Fig. 5) , inhibited glutathione reductase >80%. In the experiment shown in Table V , this dose of BCNU alone led to long-term survival in only 15% (2 of 14) mice given 106 P815 cells i.p. COL alone cured none of the mice. However, the combination of BCNU and GOL produced 86% (6 of 7) long-term survivors (>422 d). No such synergistic effect was seen with boiled GOL (Table V) . The combination of BCNU and GOL was not tested against P388 lymphoma, because BCNU alone produced 100% long-term survivors when given after as many as 107 P388 cells (not shown).
Toxicity of GOL.
Mice injected with 1 ml GOL i.p. appeared healthy throughout the period of observation (up to 441 d). Among >300 mice injected with GOL, no deaths could be attributed to this agent. Erythrocyte counts and serum levels of glucose, urea, creatinine, bilirubin, glutamic-pyruvic transaminase, and creatine phosphokinase (CPK) were measured before GOL and at intervals up to 1 wk after its injection into mice exposed to 100% 02 for 3.5 h. The results are given in Table VI. The blood tests remained normal, except for a single low erythrocyte count and elevated CPK values after the 8th hour. The results of complete autopsies performed up to 10 mo after injection of GOL were described above.
Effect of Preformed He Oe and Organic
Hydroperoxides. 30 mmol H202/kg i.p. was lethal within -30 s, probably because of the formation of O2 emboli after contact of H202 with erythrocyte catalase (27, 28) . After 10 mmol H202/kg i.p., mice looked severely ill, but recovered. The latter dose of H202 extended the survival of mice given 106 P388 cells immediately beforehand from 12.4 + 0.7 to 15.2 + 0.5 d. Mice given 106 P815 cells i.p., followed by 10 mmol H202/kg i.p., lived no longer than controls given 0.9% NaC1 alone. Ethylhydroperoxide and cumenehydroperoxide were injected i.p. in the expectation of avoiding gas formation. Both, however, were highly toxic, even at doses as low as 1 mmol/kg.
Discussion
It is of considerable interest to learn whether any proposed mediator of cytotoxicity can exert an antitumor effect in vivo. Possible obstacles to in vivo efficacy include the size of the anatomic compartments, the chemically reactive nature of the extracellular fluids, washout by the blood and lymph, metabolism by adjacent and distant tissues, and the intermingling of normal and neoplastic cells.
Hydrogen peroxide contributes to the lysis of tumor cells by macrophages and granulocytes in a variety of experimental settings in vitro (2-13).x The studies reported here showed that H202 generated by a solid-phase enzyme can also kill tumor cells in vivo, in the peritoneal cavity, without harm to the host.
To be effective, the enzyme that generated H202 had to be coupled to particles. Soluble glucose oxidase, given in maximum sublethal doses, did not kill an appreciable number of tumor cells, perhaps because it left the peritoneal cavity too quickly. A single injection of preformed H202 killed substantial numbers of tumor cells in the peritoneal cavity, but only at doses nearly lethal to the mice. Organic hydroperoxides were even more toxic than H202. In contrast, glucose oxidase coupled to latex particles was able to destroy up to 99.6% of an i.p. inoculum of 106 P388 lymphoma cells, and 100% of smaller inocula, without evident toxicity. That the effects of GOL were mediated by H202 is supported by three lines of evidence: increased antitumor activity after augmenting the concentration of the substrate, 02; abolition of the antitumor effect by boiling the GOL to inactivate the enzyme; and complete protection of the tumor cells by simultaneous injection of catalase coupled to latex particles. The latter result militates against glucose consumption or acid production playing an important role in the antitumor action of GOL.
The possibility remains that the H202 produced by GOL elicits inflammatory changes, which in turn suppress tumor growth. Two considerations make this unlikely. First is the minimal extent of inflammation detected histologically. From 3 to 20 h after injection, there was a scant neutrophilic exudate. After -3 h, the vast majority of beads came together in a limited number of tightly packed aggregates. During the first week, these aggregates were infiltrated by macrophages, which ingested the beads. Autopsies at intervals up to 10 mo after the injection of GOL revealed no other inflammatory changes. Second, GOL exerted an antitumor effect for up to 1 h after its injection, but not thereafter. As noted, cellular inflammatory changes only became detectable later.
In contrast to the results with P388 lymphoma, GOL alone was ineffective against P815 mastocytoma, a more peroxide-resistant tumor (19) . In vitro, BCNU inhibited glutathione reductase in P815 cells and thereby sensitized them to lysis by H202 generated by glucose oxidase (19) . Doses of BCNU well tolerated by the mice also inhibited P815 cell glutathione reductase in vivo. As predicted, the combination of GOL and BCNU apparently cured mice given 106 P815 cells i.p. However, proof is lacking that the synergistic interaction between GOL and BCNU in vivo had the same basis as that observed in vitro.
Supplemental 02, but not glucose, enhanced the antitumor effect of GOL. In mouse arterial blood, the concentrations of 02 and glucose are normally ~0.14 and 9.6 mM, respectively (25) . In the peritoneal cavity, the 02 concentration is lower, probably -0.06 mM (26) . With GOL, we observed a Km for oxygen of 0.01 mM and a Km for glucose of 16.7 mM. However, these values, or the wide-ranging values reported from experiments in which soluble glucose oxidase was used (20, (22) (23) (24) , may be misleading under the conditions prevailing in the peritoneal cavity after the injection of GOL. For example, assuming no replenishment, GOL would be calculated to exhaust the content of O2 in the injected fluid in -3 min. In that time, the glucose content in the same fluid would be expected to have diminished by only 9%. Thus, regardless of the Kms, it is plausible that 02 rather than glucose would be rate limiting for the production of H202 by GOL in the peritoneal cavity. The actual rate of H202 production by GOL in vivo was not determined, but presumably was much lower than that measured under standard assay conditions in vitro (Table I) .
GOL did not appear to be toxic to mice observed for about half their normal lifespan, as judged by their appearance and by complete post-mortem examinations. For up to 1 wk after injection of GOL, normal values were recorded for the erythrocyte count, blood glucose, and tests of function of the kidneys and liver. However, CPK was elevated in most of the samples assayed. It is doubtful that this elevation is significant, inasmuch as histologic changes were not noted in the heart, brain, or skeletal muscle, the usual sources of clinically significant serum concentrations of CPK. Trauma to muscle may have released CPK into the wound during collection of blood samples from the axillary vessels, giving artifactual elevations.
The basis for the apparently selective toxicity of GOL toward tumor cells rather than normal host tissues is not known. Various cells differ markedly in their susceptibility or resistance to H202 (2, 17, 19) . It has not been determined whether the cells comprising the intraabdominal tissues are more resistant to H202 than the tumor cells used in these experiments. It is possible that normal cells are protected against H202 not only by intrinsic antioxidant defenses but also by washout and catabolism of H202 in the circulation by which they are served.
In the National Cancer Institute's prescreening program for new drugs, CD2F1 mice are given 106 P388 cells i.p., followed by five daily injections of the agent under study. A trial is considered positive if survival is prolonged 20%. 3 In this report, we administered GOL or H202 only once per mouse. It would be of interest to test multiple injections of these agents, and to investigate possible enhancement of their effects by peroxidases and by inhibitors of H2Oe catabolism other than BCNU.
Over the past 30 yr, there have been numerous attempts to treat tumor-bearing patients or animals with H202. As a single agent, preformed H202 has usually been ineffective when injected into a solid tumor or into the circulation (29) (30) (31) (32) (33) (34) (35) . On the other hand, animals with malignant ascites were said to survive longer than controls after injection of H202 into the peritoneal cavity (33, 36, 37) . Unfortunately, none of the latter studies presented full data on this point.
In 1920, Oliver and Murphy (27) gave H202 by vein to patients who appeared to be dying of pneumonia in an attempt to generate oxygen through the catalatic decomposition of H202 in the bloodstream. The dramatic recovery of some of their patients encouraged other investigators to use parenteral H202 to increase the oxygen tension in tumors during radiotherapy (29, 32, (38) (39) (40) (41) or chemotherapy (34, 35, 37, 38) . Enhancement of the effect of radiotherapy or chemotherapy was usually claimed, although none of the clinical trials and few of the studies in animals were adequately controlled. In one well-designed study, radiation therapy was more effective when H202 was given intravenously 20 s before but not when given 5 min before or immediately after irradiation (29) . Such results strongly suggested that H202 acted by enhancing the oxygen effect of radiation rather than by injuring tumor cells directly (29) . Enhanced oxygenation has also been invoked to explain the enhancement of chemotherapy by H202 (35) .
The antitumor effects of H202 generated by glucose oxidase cannot be attributed to enhanced tumor oxygenation because glucose oxidase consumes more oxygen than catalase releases. 4 To our knowledge, the only previous report on the administration of glucose oxidase to tumor-bearing animals involved a single, incompletely controlled experiment in which the glucose oxidase was mixed with catalase (42) . Prolongation of survival of the treated animals was attributed to glucose consumption (42) .
Thus, we believe that ours is the first report to establish convincingly that H202 can exert a direct antitumor effect in vivo and thereby prolong the survival of the host. Injection of solid-phase glucose oxidase into the tumor bed was not associated with significant toxicity by the criteria employed. observations (35, 37) that H202 can synergize in vivo with certain antitumor drugs already in clinical use. These findings help lay the groundwork for experimental therapies based on oxidative injury of tumor cells. Summary Glucose oxidase, covalently coupled to polystyrene microspheres (GOL), produced H202 at an average rate of 3.6 nmol/min per 109 beads under standard assay conditions. Injection of 1.3 × 101° to 1.1 × 10 ix GOL i.p. prolonged the survival of mice by 27% after injection of 106 P388 lymphoma cells in the same site, consistent with destruction of 97.6% of the tumor cells. Placing mice for several hours in 100% O~, the probable rate-limiting substrate for GOL, afforded a 42% prolongation of survival from P388 lymphoma, consistent with destruction of 99.6% of the tumor cells. When the P388 inoculum was 105, 104, or 10 a cells, GOL led to long-term survival (presumed cure) of 23%, 77%, and 92% of the mice, respectively, consistent with reduction of the injected tumor dose to <10 cells. Subcutaneous growth of 105 P388 cells (~300 lethal dose to 50% of mice) was suppressed in 83% of mice by admixture of GOL with the tumor cell inoculum. GOL alone had no effect against a more peroxide-resistant tumor, P815 mastocytoma. However, P815 cell glutathione reductase could be inhibited in vivo by well-tolerated doses of the antitumor agent, 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU). BCNU alone cured few mice with P815. Together, BCNU and GOL apparently cured 86% of mice injected with 106 P815 cells i.p. The protective effect of GOL was abolished by boiling it to inactivate the enzyme, by co-injection of catalase coupled to latex beads, or by delaying the injection of tumor cells for 3 h, by which time the beads had formed aggregates. Soluble glucose oxidase, in doses threefold higher than that bound to GOL, had no detectable antitumor effect. A single injection of preformed H202 readily killed P388 cells in the peritoneal cavity, but only at doses nearly lethal to the mice. In contrast, GOL had very little toxicity, as judged by the normal appearance of the mice for over 400 d, gross and microscopic findings at autopsy, and various blood tests. GOL injected i.p. remained in the peritoneal cavity, where it was gradually organized into granulomata by macrophages, without generalized inflammation. Thus, an H202-generating system confined to the tumor bed exerted clear-cut antitumor effects with little toxicity to the host.
